Fortis Healthcare Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings
- October 9, 2026
- Posted by: Chaitanya Auti
- Category: Market
Fortis Healthcare share price Rs 779.80 (9 October 2026). Base target Rs 917, bull Rs 1,099, downside risk Rs 611. PE 53.88. 52W range Rs 745.35 to Rs 1,104.30.
Quick Answer
The Fortis Healthcare share price target for 2027 is Rs 917, about 17.6% above the current price of Rs 779.80. The bull case is Rs 1,099, and the downside risk level, which is not a target, is Rs 611. The base case assumes earnings per share grow 20.0% a year, a cap applied because the FY24 to FY26 pace was 31.9%, with the stock holding its PE of 53.88. These are model-based estimates built from reported financials, not guaranteed outcomes.
Investors weighing a Fortis Healthcare target price for 2027 should start with where the stock sits today. At Rs 779.80 on 9 October 2026, it is 29.4% below its 52-week high of Rs 1,104.30 and 4.6% above its 52-week low of Rs 745.35. That range spans 48% from low to high, so the entry point matters as much as the Fortis Healthcare price forecast itself.
This article builds the Fortis Healthcare share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 917 base case and the Rs 1,099 bull case were reached, along with a downside risk level of Rs 611.
Click Here – Get Free Investment Predictions
Fortis Healthcare Stock Analysis: Company Overview and Key Stats
Fortis Healthcare (NSE: FORTIS) has a market capitalisation of Rs 57,679 crore. In FY26 it reported revenue of Rs 9,178 crore and net profit of Rs 1,064 crore. The table collects the figures the Fortis Healthcare share price target is built on.
| Metric | Value |
|---|---|
| Company | Fortis Healthcare |
| NSE Ticker | FORTIS |
| CMP (9 October 2026) | Rs 779.80 |
| 52-Week High | Rs 1,104.30 |
| 52-Week Low | Rs 745.35 |
| Market Cap | Rs 57,679 crore |
| PE Ratio (TTM) | 53.88 |
| Industry PE | 62.79 |
| Price to Book | 5.83 |
| Return on Equity | 10.53% |
| Debt to Equity | 0.35 |
| EPS (TTM) | Rs 14.18 |
| Dividend Yield | 0.13% |
| 12-Month Base Target | Rs 917 |
| Bull Case | Rs 1,099 |
| Downside Risk Level (not a target) | Rs 611 |
Why Is Fortis Healthcare Share Price Target Set at Rs 917 for 2027?
The base-case Fortis Healthcare stock target of Rs 917 applies a PE multiple of 53.88 to a forward EPS estimate of Rs 17.02. That EPS assumes 20.0% yearly growth, the pace from FY24 to FY26, and puts the target 17.6% above the current price. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.
Earnings Growth Behind the Fortis Healthcare Target Price: Five Years of Results
Fortis Healthcare grew revenue from Rs 5,745 crore in FY22 to Rs 9,178 crore in FY26, a compound annual growth rate of 12.4%. Net profit grew more slowly, from Rs 789.95 crore to Rs 1,064 crore (7.7% a year), which points to margin pressure alongside the sales growth.
| Financial Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Dividend per Share (Rs) |
|---|---|---|---|---|
| FY22 | 5,744.95 | 789.95 | 7.35 | 0.00 |
| FY23 | 6,359.35 | 632.98 | 7.80 | 1.00 |
| FY24 | 6,931.17 | 645.22 | 7.93 | 1.00 |
| FY25 | 7,849.69 | 809.38 | 10.26 | 1.00 |
| FY26 | 9,178.50 | 1,064.19 | 13.80 | 1.00 |
FY26 revenue growth was 16.9%, faster than the four-year average of 12.4%, and net profit moved up 31.5%. EPS rose from Rs 7.93 in FY24 to Rs 13.80 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.
Margins and the Latest Quarter
Fortis Healthcare converted 11.6% of FY26 revenue into net profit, against 10.3% in FY25, within a five-year range of 9.3% to 13.8%. EBITDA margin was 23.2% in FY26 versus 20.1% in FY25.
In the June 2026 quarter, revenue was Rs 2,560 crore, up 17.3% from the same quarter a year earlier, while net profit of Rs 272.80 crore was up 2.3%. EBITDA came in at Rs 551.59 crore, up 9.0% year on year. The next quarterly result is the first test of whether the earnings assumption holds.
Balance Sheet and Cash Flow
Debt to equity stands at 0.35, and shareholders’ equity grew from Rs 7,008 crore in FY22 to Rs 10,168 crore in FY26. Operating cash flow in FY26 was Rs 1,601 crore against capital expenditure of Rs 945.44 crore, leaving free cash flow of Rs 656.01 crore, or 1.1% of the current market capitalisation. In FY25 free cash flow was Rs 576.99 crore.
Valuation Check for the Fortis Healthcare Stock Target: PE, Price to Book and ROE
At a PE of 53.88 against an industry PE of 62.79, Fortis Healthcare trades at a discount to its industry. Price to book is 5.83 on a book value of Rs 131.07 per share, and return on equity is 10.53%. A PE of 53.88 equals an earnings yield of 1.9%, and the FY26 dividend of Rs 1.00 per share gives a yield of 0.13%.
Shareholding Pattern and Institutional Holding
Promoters held 31.17% of Fortis Healthcare in June 2026, and promoter holding has stayed near 31.17% since June 2025. Foreign institutional investors (FII) held 25.20% and domestic institutions (DII) held 32.23%, which puts total institutional holding at 57.43%. FII holding fell from 27.17% in June 2025 to 25.20% in June 2026. Public shareholders own the remaining 11.40%. A meaningful institutional holding adds a layer of research coverage and trading depth.
Fortis Healthcare Share Price Targets for the Short Term and 12 Months
Short Term Fortis Healthcare Stock Target Levels: Technical Setup
At Rs 779.80 on 9 October 2026, Fortis Healthcare trades below its 50-day simple moving average of Rs 888.06 and below its 200-day exponential moving average of Rs 922.88. The 14-day RSI reads 26.1, which is oversold territory, and the MACD line sits below its signal line. The nearest resistance level is Rs 888.06 (50-day simple moving average) and the nearest support is Rs 745.35 (52-week low). A sustained move above Rs 888.06 would improve the short-term setup, while a close below Rs 745.35 would shift attention to the next support.
12 Month Fortis Healthcare Target Price for 2027
The 12-month target for Fortis Healthcare is Rs 917: forward EPS of Rs 17.02 at a PE of 53.88. That is 17.6% above Rs 779.80. It would still leave the stock 17.0% below its 52-week high of Rs 1,104.30.
How EPS Growth and PE Multiple Change the Fortis Healthcare Target Price
| EPS Growth | PE 43.10 | PE 53.88 | PE 61.96 |
|---|---|---|---|
| 0.0% (EPS Rs 14.18) | Rs 611 | Rs 764 | Rs 879 |
| 20.0% (EPS Rs 17.02) | Rs 734 | Rs 917 | Rs 1,055 |
| 25.0% (EPS Rs 17.73) | Rs 764 | Rs 955 | Rs 1,099 |
Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Fortis Healthcare price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.
Bull Case and Downside Risk for Fortis Healthcare Stock Target in 2027
Bull Case Rs 1,099
The bull case Fortis Healthcare price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 17.73, and a PE multiple that rises 15% to 61.96. That gives Rs 1,099, 40.9% above the current price and below the 52-week high of Rs 1,104.30.
Downside Risk Level Rs 611
The downside risk level is not a target. It assumes EPS stays flat at Rs 14.18 and the PE falls 20% to 43.10. That gives Rs 611, 21.6% below the current price and below the 52-week low of Rs 745.35.
| Scenario | EPS Growth | PE Multiple | Price (Rs) | Change vs CMP |
|---|---|---|---|---|
| Bull Case | 25.0% | 61.96 | Rs 1,099 | +40.9% |
| Base Case | 20.0% | 53.88 | Rs 917 | +17.6% |
| Downside Risk | 0.0% | 43.10 | Rs 611 | -21.6% |
Key Risks to the Fortis Healthcare Target Price for 2027
Growth Slowdown Risk for the Fortis Healthcare Price Target
Revenue in the June 2026 quarter was up 17.3% year on year, and FY26 revenue growth was 16.9%. If growth slows from here, the EPS estimate behind the Fortis Healthcare stock target will need revising.
Liquidity and Size Risk
Fortis Healthcare has a market capitalisation of Rs 57,679 crore. Institutional holding is 57.43%, and promoters hold 31.17%. A company of this size trades with deep liquidity, so entry and exit are rarely a problem, and the larger risk is paying too much for slow earnings growth.
Valuation and Margin Risk
Net margin was 11.6% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 53.88 versus an industry PE of 62.79, a de-rating toward the downside-risk PE of 43.10 would cut the price even if earnings hold.
Market and Technical Risk
The stock trades 29.4% below its 52-week high, with an RSI of 26.1 and a MACD reading below its signal line. Broader market weakness can override company fundamentals in the short term.
How to Invest in Fortis Healthcare
Start with the live price and volume. Any Fortis Healthcare share price target is only as current as the data behind it, and the data here is as of 9 October 2026, so refresh the Rs 779.80 price before acting on any level.
Next, review the fundamentals yourself. The Univest Screener lets you check Fortis Healthcare’s PE, ROE, debt and shareholding in one place.
Check Fortis Healthcare fundamentals on the Univest Screener
Then compare the three Fortis Healthcare target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.
Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.
Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.
Download the Univest iOS App or Univest Android App to track Fortis Healthcare live price and get daily stock recommendations.
Conclusion
The Fortis Healthcare share price target for 2027 is Rs 917 in the base case, with Rs 1,099 as the bull case. The support for that view is arithmetic you can check: EPS grew 31.9% a year over FY24 to FY26, and the stock trades at a PE of 53.88. The risks are equally concrete, including a stock that sits 29.4% below its 52-week high and a downside scenario that cuts the price 22% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Fortis Healthcare Share Price Target 2027
What is the Fortis Healthcare share price target for 2027?
Ans. The base-case Fortis Healthcare share price target for 2027 is Rs 917, with Rs 1,099 as the bull case. The downside risk level, which is not a target, is Rs 611. These are model estimates from reported earnings and the current PE, not guaranteed outcomes.
What is the Fortis Healthcare share price today?
Ans. As of 9 October 2026, 1:18 PM IST, Fortis Healthcare trades at Rs 779.80, up 2.20% on the day. The 52-week range is Rs 745.35 to Rs 1,104.30.
Is Fortis Healthcare a buy or sell at the current price?
Ans. The data is mixed rather than one-sided: EPS has grown 31.9% a year over FY24 to FY26, but the stock is 29.4% below its 52-week high. Whether Fortis Healthcare fits your portfolio depends on your time horizon and risk appetite, so consult a SEBI-registered advisor before investing. This article is not investment advice.
What are the bull case target and downside risk level for Fortis Healthcare shares?
Ans. The bull case target is Rs 1,099, which assumes 25.0% EPS growth and a PE of 61.96. The downside risk level is Rs 611, which assumes flat EPS and a PE of 43.10. It marks a risk, not a target.
What are the main risks to the Fortis Healthcare price target?
Ans. The main risks are slower revenue growth, a small market capitalisation of Rs 57,679 crore, a PE de-rating and short-term weakness in the broader market. Each is covered in the risk section above.
What is the PE ratio of Fortis Healthcare and how does it compare with the industry?
Ans. The PE ratio of Fortis Healthcare is 53.88 against an industry PE of 62.79. Price to book is 5.83 and return on equity is 10.53%. The base case in the Fortis Healthcare price target holds this PE constant.
Who owns Fortis Healthcare, and what is the promoter holding?
Ans. Promoters held 31.17% of Fortis Healthcare in June 2026. FII held 25.20%, DII held 32.23% and the public held 11.40%.
What were Fortis Healthcare’s latest quarterly results?
Ans. In the June 2026 quarter, Fortis Healthcare reported revenue of Rs 2,560 crore (up 17.3% year on year) and net profit of Rs 272.80 crore (up 2.3%).